公司简介

Genomas is a biomedical company bringing DNA-Guided medicine to clinical practice with products for personalized prescription of drugs

主要成员

Gualberto Rua?o、Mohan Kocherla

产品/服务

• 科技服务

PhyzioType Systems	The most commonly used medication for individualized treatment.
PIMS PhyzioType System	Predict the risk of drug-induced pre-diabetes and metabolic symptoms caused by AAP.
SINM PhyzioType System	Doctors offer drug-specific efficacy predictions for reduced LDL, elevated HDL, and risk characteristics for neuromuscular side effects of atorvastatin, rosuvastatin, and simvastatin.
GLIM PhyzioType System	Provides efficacy and safety predictions for both the thiazolidinedione (TZD) drugs pioglitazone and rosiglitazone and the enteric-lowering drugs exenatide and sitagliptin.
Phyziogenomics Technology	A proprietary platform that integrates genotypic and phenotypic measurements.

融资信息

融资轮次	融资日期	投资方	融资额度
B轮	2007-06	未披露	$1M
C轮	2007-10	未披露	$2.5M
债务融资	2009-04	未披露	$500k

关联公司